Description
Product details
Darcept 40 Injection is an erythropoiesis-stimulating medicine used to manage anaemia associated with chronic kidney disease (CKD) and chemotherapy-related anaemia. It works by stimulating bone marrow activity to increase red blood cell production and support appropriate haemoglobin levels. Benefits of Darcept 40 Injection CKD-Associated Anaemia Reduced kidney function can interfere with normal red blood cell production. Darcept 40 Injection helps stimulate the formation of new red blood cells and may help manage symptoms of renal anaemia such as fatigue, weakness and reduced energy. Chemotherapy-Related Anaemia Certain chemotherapy treatments may suppress red blood cell production and lower haemoglobin levels. Darcept 40 may be prescribed for suitable cancer patients to support red blood cell formation and haemoglobin management during chemotherapy. How to Use Darcept 40 Injection should be administered only by a doctor, nurse or qualified healthcare professional. The dose and treatment schedule depend on the patient's haemoglobin level, clinical condition and response to therapy. Do not self-administer unless specifically instructed and trained by your healthcare professional. Possible Side Effects Reported side effects may include: High blood pressure (hypertension) Hypersensitivity reactions Seek medical advice promptly if you experience severe headache, vision changes, breathing difficulty, skin rash, seizures or other serious symptoms. Monitoring & Precautions During treatment, your healthcare professional may monitor haemoglobin, blood cell counts, blood pressure and electrolytes such as potassium. Follow the prescribed treatment schedule and recommended laboratory monitoring carefully.
